A significant challenge confronting patients is the misclassification of T1D as type 2 diabetes. Alarmingly, 40% of adults with T1D are initially diagnosed with type 2 diabetes.

In pediatric cases, DKA (diabetic ketoacidosis) is frequently the indicator of misclassification. Moreover, a type 2 diabetes diagnosis results in the loss of a crucial opportunity for T1D early detection and intervention.

Clinical guidelines issued by the American Diabetes Association (ADA) recommend T1D-related autoantibody testing in:
-Those with a family history of type 1 diabetes, or
-A known elevated genetic risk, especially those with certain autoimmune diseases, such as autoimmune thyroid disorders and celiac disease, or
-Adults with phenotypic risk factors that overlap with those for T1D

Early detection also plays a critical role in preserving beta cell function.

Even low levels of remaining beta cells can:

-Improve blood sugar control
-Reduce the risk of severe hypoglycemia
-Lower the risk of short- and long-term complications

Type 1 and Type 2 diabetes both cause high blood sugar, but they have different causes. Type 1 is an autoimmune disease where the body stops making insulin. Type 2 is a metabolic condition where the body makes insulin but does not use it well

Type 1 diabetes symptoms typically appear fast, often over a few days or weeks. Common signs include extreme thirst, frequent peeing (including bed-wetting in children), constant hunger, rapid and unintended weight loss, and severe tiredness. These occur because the body lacks insulin and cannot use sugar for energy

Managing type 1 diabetes requires lifelong daily insulin therapy, frequent blood sugar monitoring, and matching insulin doses to the carbohydrates you eat. The primary goal is to keep your blood glucose levels within a safe, targeted range to prevent short-term emergencies and long-term health complications